{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:55:35Z","timestamp":1793066135211,"version":"4.5.0"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.semcancer.2017.02.009","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:52:50Z","timestamp":1488329570000},"page":"65-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":550,"special_numbering":"C","title":["From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy"],"prefix":"10.1016","volume":"46","author":[{"given":"Thomas","family":"Efferth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2017.02.009_bib0005","first-page":"366","article-title":"Studies on the constituents of Artemisia annua L. (author's transl)","volume":"16","author":"Tu","year":"1981","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0010","first-page":"35","article-title":"The constituents of young Artemisia annua","volume":"10","author":"Tu","year":"1985","journal-title":"Zhong Yao Tong Bao"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0015","first-page":"250","article-title":"The development of the antimalarial drugs with new type of chemical structure?qinghaosu and dihydroqinghaosu","volume":"35","author":"Tu","year":"2004","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0020","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/S0040-4039(01)96314-2","article-title":"New type of sesquiterpene lactones isolated from Artemisia annua L. arteannuin B","volume":"14","author":"Jeremic","year":"1973","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1475-2875-13-463","article-title":"Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review","volume":"13","author":"Visser","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0030","first-page":"CD011547","article-title":"Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria","volume":"2","author":"Isba","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12936-015-0919-5","article-title":"A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria","volume":"14","author":"Naing","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","author":"WWARN","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-015-0445-x","article-title":"Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data","volume":"13","author":"WWARN","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12936-015-0649-8","article-title":"Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania","volume":"14","author":"Shayo","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0055","doi-asserted-by":"crossref","first-page":"189232","DOI":"10.1155\/2015\/189232","article-title":"Adherence to artemisinin-Based combination therapy for the treatment of uncomplicated malaria: a systematic review and meta-Analysis","volume":"2015","author":"Yakasai","year":"2015","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","article-title":"Artemisinin: discovery from the Chinese herbal garden","volume":"146","author":"Miller","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0065","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1172\/JCI60887","article-title":"From branch to bedside: youyou Tu is awarded the 2011 Lasker\u223cDeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria","volume":"121","author":"Neill","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0070","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0075","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.phymed.2015.10.003","article-title":"Nobel Prize for artemisinin brings phytotherapy into the spotlight","volume":"22","author":"Efferth","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/parasite\/1994011005","article-title":"The redox status of malaria-infected erythrocytes: an overview with an emphasis on unresolved problems","volume":"1","author":"Ginsburg","year":"1994","journal-title":"Parasite"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0085","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum","volume":"275","author":"Shenai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0090","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1021\/ja00126a042","article-title":"Oh CH. Evidence for Fe(IV)jO in the molecular mechanism of action of the trioxane antimalarial artemisinin","volume":"117","author":"Posner","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","article-title":"Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action","volume":"37","author":"Cumming","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0100","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O'Neill","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0105","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","article-title":"Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite","volume":"274","author":"Pandey","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0110","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/cmdc.201100184","article-title":"A partial convergence in action of methylene blue and artemisinins: antagonism with chloroquine, a reversal with verapamil, and an insight into the antimalarial activity of chloroquine","volume":"6","author":"Haynes","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0115","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/srep02513","article-title":"A plausible mechanism for the antimalarial activity of artemisinin: a computational approach","volume":"3","author":"Shandilya","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2014.07.011","article-title":"Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate","volume":"158","author":"Lisewski","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0125","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.45.8.2397-2399.2001","article-title":"Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies","volume":"45","author":"Bhisutthibhan","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","article-title":"Artemisinins target the SERCA of Plasmodium falciparum","volume":"424","author":"Eckstein-Ludwig","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.febslet.2004.08.039","article-title":"Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin","volume":"575","author":"Parapini","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation","volume":"6","author":"Li","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1756-3305-4-201","article-title":"Jiang MS: Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis","volume":"4","author":"Liu","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0155","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.phymed.2016.06.004","article-title":"Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines","volume":"23","author":"Jiang","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","article-title":"Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin","volume":"91","author":"Lai","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0175","first-page":"196","article-title":"Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs","volume":"46","author":"Efferth","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2006-959408","article-title":"Cytotoxic terpenoids and flavonoids from Artemisia annua","volume":"60","author":"Zheng","year":"1994","journal-title":"Planta Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1055\/s-2006-957533","article-title":"Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells","volume":"64","author":"Beekman","year":"1998","journal-title":"Planta Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ptr.4758","article-title":"Biochemical and haematological evaluation of repeated dose exposure of male Wistar rats to an ethanolic extract of Artemisia annua","volume":"27","author":"Eteng","year":"2013","journal-title":"Phytother. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","article-title":"Artemisinins target GABAA receptor signaling and impair alpha cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138945006776359412","article-title":"Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells","volume":"7","author":"Efferth","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2007-967138","article-title":"Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin?from bench to bedside","volume":"73","author":"Efferth","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0220","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.phymed.2015.01.012","article-title":"Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres","volume":"22","author":"Seo","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0225","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2016.06.128","article-title":"High-throughput screening identifies artesunate as selective inhibitor of cancer stemness: involvement of mitochondrial metabolism","volume":"477","author":"Subedi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000076256","article-title":"Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR\/flk-1","volume":"71","author":"Chen","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0235","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","article-title":"Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate","volume":"68","author":"Dell'Eva","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0240","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","article-title":"Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo","volume":"65","author":"Disbrow","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0245","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.22804","article-title":"Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway","volume":"121","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0250","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CAD.0b013e3283212ade","article-title":"Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo","volume":"20","author":"Chen","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0260","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0265","first-page":"3807","article-title":"Artemisinin-transferrin conjugate retards growth of breast tumors in the rat","volume":"29","author":"Lai","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1534735408330714","article-title":"Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model","volume":"8","author":"Wu","year":"2009","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0275","doi-asserted-by":"crossref","first-page":"e20550","DOI":"10.1371\/journal.pone.0020550","article-title":"Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells","volume":"6","author":"Bachmeier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0280","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.intimp.2011.07.008","article-title":"Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo","volume":"11","author":"Farsam","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0285","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10495-011-0580-6","article-title":"Interruption of the MEK\/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo","volume":"16","author":"Gao","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0290","doi-asserted-by":"crossref","first-page":"e23943","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CAD.0b013e32834f6ea8","article-title":"Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes","volume":"23","author":"Tin","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0300","first-page":"101","article-title":"Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer","volume":"27","author":"Wu","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0305","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","article-title":"Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo","volume":"83","author":"Zhang","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0310","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3892\/or.2013.2658","article-title":"Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt\/beta-catenin signaling","volume":"30","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0315","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1007\/s13277-013-0963-0","article-title":"Anti-cancer activity of DHA on gastric cancer\u2013an in vitro and in vivo study","volume":"34","author":"Sun","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0320","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/CAD.0b013e328364a109","article-title":"Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo","volume":"24","author":"Zhou","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13659-014-0024-4","article-title":"Differential effect of artemisinin against cancer cell lines","volume":"4","author":"Tilaoui","year":"2014","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0330","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MEG.0000000000000066","article-title":"Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent","volume":"26","author":"Vandewynckel","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2014.03.026","article-title":"DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal","volume":"71","author":"Zhu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0340","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.3390\/ijms150814298","article-title":"Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression","volume":"15","author":"Zuo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0345","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00280-016-3038-2","article-title":"Evaluation of artemisinins for the treatment of acute myeloid leukemia","volume":"77","author":"Drenberg","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0350","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2016.04.061","article-title":"Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling","volume":"82","author":"Ilamathi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0355","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.3892\/mmr.2016.5073","article-title":"Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis","volume":"13","author":"Jia","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0360","doi-asserted-by":"crossref","first-page":"e0147157","DOI":"10.1371\/journal.pone.0147157","article-title":"Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2\/STAT3 signaling","volume":"11","author":"Jia","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0365","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10723","article-title":"Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy","author":"Lemke","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0370","article-title":"Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0375","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0380","doi-asserted-by":"crossref","first-page":"31413","DOI":"10.18632\/oncotarget.8920","article-title":"Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt\/beta-catenin signaling","volume":"7","author":"Tong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0385","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mc.22474","article-title":"Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0390","first-page":"1","article-title":"Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1\/2 and p38 MAPK signaling pathways","volume":"12","author":"Zhang","year":"2016","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0395","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/mmr.2015.3517","article-title":"Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0400","doi-asserted-by":"crossref","first-page":"19074","DOI":"10.1038\/srep19074","article-title":"Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts","volume":"6","author":"Feng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0006-2952(02)01221-2","article-title":"mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether","volume":"64","author":"Efferth","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcp.2004.03.003","article-title":"Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines","volume":"68","author":"Efferth","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0420","first-page":"225","article-title":"Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate","volume":"19","author":"Efferth","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0425","first-page":"1231","article-title":"Role of antioxidant genes for the activity of artesunate against tumor cells","volume":"23","author":"Efferth","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0430","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0435","first-page":"149","article-title":"Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate","volume":"35","author":"Sieber","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0440","doi-asserted-by":"crossref","first-page":"046028","DOI":"10.1117\/1.3481141","article-title":"Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques","volume":"15","author":"Lu","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0445","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/030089161109700615","article-title":"Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells","volume":"97","author":"Gao","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0450","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10637-011-9676-7","article-title":"The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis","volume":"30","author":"Cabello","year":"2012","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0455","doi-asserted-by":"crossref","first-page":"e37222","DOI":"10.1371\/journal.pone.0037222","article-title":"Dihydroartemisinin enhances Apo2L\/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0460","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fob.2012.05.002","article-title":"Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity","volume":"2","author":"Wang","year":"2012","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0465","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1002\/jcp.24086","article-title":"Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells","volume":"227","author":"Zhou","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0470","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10495-013-0857-z","article-title":"Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9, \u22128 and \u22123","volume":"18","author":"Gao","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0475","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biochi.2014.10.001","article-title":"Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis","volume":"107","author":"Ganguli","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0480","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-9966-33-8","article-title":"The activation of c-Jun NH(2)-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells","volume":"33","author":"Jia","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0485","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1007\/s13277-014-1691-9","article-title":"Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondria-dependent pathway","volume":"35","author":"Lu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0490","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11655-013-1454-2","article-title":"Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line","volume":"20","author":"Noori","year":"2014","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0495","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.18632\/oncotarget.1847","article-title":"Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis","volume":"5","author":"Papanikolaou","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0500","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/carcin\/bgv098","article-title":"Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells","volume":"36","author":"Beccafico","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0505","first-page":"1867","article-title":"Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells","volume":"35","author":"Gerhardt","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0510","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(06)80014-5","article-title":"Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat","volume":"98","author":"Moore","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0024-3205(01)01372-8","article-title":"Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells","volume":"70","author":"Singh","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0525","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron","volume":"37","author":"Efferth","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0530","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1371\/journal.pone.0000798","article-title":"Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate","volume":"2","author":"Kelter","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0535","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13238-014-0119-z","article-title":"Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0540","first-page":"2277","article-title":"Artemisinin induces apoptosis in human cancer cells","volume":"24","author":"Singh","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0545","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.lfs.2004.08.020","article-title":"Effects of artemisinin-tagged holotransferrin on cancer cells","volume":"76","author":"Lai","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0550","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1517\/14728222.9.5.995","article-title":"Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds","volume":"9","author":"Lai","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0555","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4161\/cbt.7.7.6035","article-title":"Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0560","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2008.09.023","article-title":"Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis","volume":"274","author":"Nakase","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0565","doi-asserted-by":"crossref","first-page":"e7472","DOI":"10.1371\/journal.pone.0007472","article-title":"Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0570","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Hamacher-Brady","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0575","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10637-010-9481-8","article-title":"The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells","volume":"29","author":"Lu","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0580","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/jbc.M110.144188","article-title":"The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials","volume":"286","author":"Mercer","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0585","doi-asserted-by":"crossref","first-page":"e42703","DOI":"10.1371\/journal.pone.0042703","article-title":"Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1","volume":"7","author":"Ba","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0590","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.bmc.2013.04.059","article-title":"Gomez-San Miguel AB, Alvarez M, et al: novel artemisinin derivatives with potential usefulness against liver\/colon cancer and viral hepatitis","volume":"21","author":"Blazquez","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0595","first-page":"4389","article-title":"Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine","volume":"33","author":"Chan","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0600","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/or.2013.2574","article-title":"Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71","volume":"30","author":"Zhao","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0605","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1292\/jvms.13-0319","article-title":"Erythrophagocytosis enhances heme-dependent cytotoxicity of antimalarial drugs in canine histiocytic sarcoma cell line DH82","volume":"76","author":"Chikazawa","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0610","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2014.03.044","article-title":"Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin","volume":"467","author":"Yang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0615","doi-asserted-by":"crossref","first-page":"33046","DOI":"10.18632\/oncotarget.5422","article-title":"Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis","volume":"6","author":"Jeong DE SH","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0620","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0625","doi-asserted-by":"crossref","first-page":"e0137331","DOI":"10.1371\/journal.pone.0137331","article-title":"Mechanisms of dihydroartemisinin and Dihydroartemisinin\/Holotransferrin cytotoxicity in T-Cell lymphoma cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0630","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4162\/nrp.2016.10.4.393","article-title":"Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma","volume":"10","author":"Kim","year":"2016","journal-title":"Nutr. Res. Pract."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0635","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0640","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","article-title":"Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells","volume":"381","author":"Lin","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0645","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0014-2964(80)90181-4","article-title":"Lysosomal accumulation of 67Ga\u2013transferrin in malignant tumors in relation to their growth rate","volume":"16","author":"Aulbert","year":"1980","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0650","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000163611","article-title":"Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines","volume":"59","author":"Shterman","year":"1991","journal-title":"Pathobiology"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0655","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.36.5.539","article-title":"Transferrin receptors in human tissues: their distribution and possible clinical relevance","volume":"36","author":"Gatter","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0660","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1084\/jem.152.5.1430","article-title":"Novel surface antigen expressed on dividing cells but absent from nondividing cells","volume":"152","author":"Judd","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0665","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1073\/pnas.78.5.3039","article-title":"Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin","volume":"78","author":"Trowbridge","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0670","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1073\/pnas.78.7.4515","article-title":"Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin","volume":"78","author":"Sutherland","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0675","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0680","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0685","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0690","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jat.1734","article-title":"In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)","volume":"33","author":"Alcantara","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0695","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4238\/2013.July.24.6","article-title":"Genotoxic evaluation of the antimalarial drugs artemisinin and artesunate in human HepG2 cells and effects on CASP3 and SOD1 gene expressions","volume":"12","author":"Aquino","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0700","first-page":"1339","article-title":"DNA damage in dihydroartemisinin-resistant Molt-4 cells","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0705","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/15384047.2015.1071738","article-title":"Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51","volume":"16","author":"Wang","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0710","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1745-7254.2007.00612.x","article-title":"Dihydroartemisinin is an inhibitor of ovarian cancer cell growth","volume":"28","author":"Jiao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0715","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00432-009-0731-0","article-title":"Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB","volume":"136","author":"Chen","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0720","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","article-title":"Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NFkappaB p65","volume":"90","author":"Li","year":"2009","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0725","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1074\/jbc.M804491200","article-title":"Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression","volume":"284","author":"Willoughby","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0730","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/jm100404t","article-title":"Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells","volume":"53","author":"Horwedel","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0735","first-page":"337","article-title":"Efferth T.v Effects of artesunate on cytokinesis and G(2)\/M cell cycle progression of tumour cells and budding yeast","volume":"7","author":"Steinbr\u00fcck","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0716-6","article-title":"Anti-tumor effects of dihydroartemisinin on human osteosarcoma","volume":"351","author":"Ji","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0745","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jcb.23114","article-title":"Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells","volume":"112","author":"Wu","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0750","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/CAD.0b013e328350e8ac","article-title":"Artesunate induces G0\/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells","volume":"23","author":"Jiang","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0755","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1007\/s11033-011-1442-6","article-title":"Artesunate inhibits cell proliferation and decreases growth hormone synthesis and secretion in GH3 cells","volume":"39","author":"Mao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0760","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2013.01.013","article-title":"Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin","volume":"67","author":"Du","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0765","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3892\/ijmm.2012.1176","article-title":"Involvement of the mitochondrial pathway and Bim\/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro","volume":"31","author":"Mao","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0770","first-page":"752","article-title":"Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3","volume":"69","author":"Cao","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0775","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/CAD.0000000000000089","article-title":"Artesunate induces G2\/M cell cycle arrest through autophagy induction in breast cancer cells","volume":"25","author":"Chen","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0780","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/CAD.0000000000000054","article-title":"Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-kappaB transcriptional signaling","volume":"25","author":"Tran","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0785","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s13277-013-1193-1","article-title":"Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0790","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/or.2014.3323","article-title":"Artemisinin reduces cell proliferation and induces apoptosis in neuroblastoma","volume":"32","author":"Zhu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0795","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3892\/ol.2015.2982","article-title":"Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma","volume":"9","author":"Shi","year":"2015","journal-title":"Oncol Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0800","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0973-1482.151855","article-title":"Dihydroartemisinin inhibits cell proliferation by induced G1 arrest and apoptosis in human nasopharyngealcarcinoma cells","volume":"12","author":"Huang","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0805","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/carcin\/bgn214","article-title":"Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells","volume":"29","author":"Sundar","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0810","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/mc.22296","article-title":"Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells","volume":"55","author":"Hargraves","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0815","first-page":"2153","article-title":"Artemisinin: an alternative treatment for oral squamous cell carcinoma","volume":"24","author":"Yamachika","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0820","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1211\/jpp.59.6.0011","article-title":"Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells","volume":"59","author":"Huang","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0825","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1358\/mf.2007.29.1.1063493","article-title":"Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells","volume":"29","author":"Mu","year":"2007","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0830","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00280-007-0517-5","article-title":"The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells","volume":"61","author":"Mu","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0835","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2460\/ajvr.69.4.519","article-title":"Biological activity of dihydroartemisinin in canine osteosarcoma cell lines","volume":"69","author":"Hosoya","year":"2008","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0840","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/CAD.0b013e328330caba","article-title":"Effect of artesunate on immune cells in ret-transgenic mouse melanoma model","volume":"20","author":"Ramacher","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0845","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bcp.2009.04.014","article-title":"Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells","volume":"78","author":"Youns","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0850","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00280-009-1129-z","article-title":"Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro","volume":"66","author":"Zhou","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0855","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/1535-7163.MCT-10-0051","article-title":"Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway","volume":"9","author":"Handrick","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0860","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4161\/cbt.9.10.11552","article-title":"Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells","volume":"9","author":"He","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0865","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2009.08.013","article-title":"Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines","volume":"79","author":"Michaelis","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0870","first-page":"1549","article-title":"Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging","volume":"31","author":"Aung","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0875","first-page":"279","article-title":"Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-kappaB and PI3K\/Akt signaling pathways","volume":"39","author":"Thanaketpaisarn","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0880","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s12253-012-9508-x","article-title":"Dihydroarteminsin-induced apoptosis is not dependent on the translocation of Bim to the endoplasmic reticulum in human lung adenocarcinoma cells","volume":"18","author":"Chen","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0885","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11010-011-1072-2","article-title":"Characterization of dihydroartemisinin-resistant colon carcinoma HCT116\/R cell line","volume":"360","author":"Lu","year":"2012","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0890","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejh.12176","article-title":"Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate","volume":"91","author":"Holien","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0895","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biopha.2012.10.017","article-title":"Dihydroartemisinin inhibits the Bcr\/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib","volume":"67","author":"Lee","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0900","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/cbt.27223","article-title":"Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2","volume":"15","author":"Hu","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0905","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/carcin\/bgt277","article-title":"Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells","volume":"35","author":"Odaka","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0910","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/jcb.25152","article-title":"Artemisinin represses telomerase subunits and induces apoptosis in HPV-39 infected human cervical cancer cells","volume":"116","author":"Mondal","year":"2015","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0915","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-015-1132-2","article-title":"Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells","volume":"20","author":"Qin","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0920","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3892\/or.2016.4847","article-title":"Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties","volume":"36","author":"Lian","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0925","first-page":"881","article-title":"Effect and mechanism of dihydroartemisinin on proliferation, metastasis and apoptosis of human osteosarcoma cells","volume":"29","author":"Tang","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0930","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7150\/ijms.11352","article-title":"Rtesunate induces SKM-1 cells apoptosis by inhibiting hyperactive beta-catenin signaling pathway","volume":"12","author":"Xu","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0935","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/CAD.0000000000000307","article-title":"Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt\/beta-catenin pathway","volume":"27","author":"Hui","year":"2016","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.05.033","article-title":"Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: an iTRAQ-based proteomic analysis","volume":"157","author":"Xu","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0945","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3892\/ol.2016.4870","article-title":"Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway","volume":"12","author":"Zhang","year":"2016","journal-title":"Oncol Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0950","doi-asserted-by":"crossref","first-page":"e1466","DOI":"10.1038\/cddis.2014.434","article-title":"Artesunate induces necrotic cell death in schwannoma cells","volume":"5","author":"Button","year":"2014","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0955","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2013.09.035","article-title":"Dihydroartemisinin induces autophagy by suppressing NF-kappaB activation","volume":"343","author":"Hu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0960","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/15384047.2015.1026477","article-title":"p8 attenuates the apoptosis induced by dihydroartemisinin in cancer cells through promoting autophagy","volume":"16","author":"Chen","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0965","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0970","doi-asserted-by":"crossref","first-page":"e02523","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0975","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0980","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.semcancer.2017.02.009_bib0985","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945011793591626","article-title":"Complex interactions between phytochemicals: the multi-target therapeutic concept of phytotherapy","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0990","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13659-013-0004-0","article-title":"Animal plant warfare and secondary metabolite evolution","volume":"3","author":"W\u00f6ll","year":"2013","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.semcancer.2017.02.009_bib0995","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1000","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00280-003-0751-4","article-title":"Antimalarial dihydroartemisinin also inhibits angiogenesis","volume":"53","author":"Chen","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2004.03.014","article-title":"Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell","volume":"211","author":"Huan-huan","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.tpj.6500371","article-title":"Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins","volume":"6","author":"Anfosso","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.cad.0000224443.85834.32","article-title":"Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion","volume":"17","author":"Wu","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","article-title":"Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells","volume":"47","author":"Zhou","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12185-010-0697-3","article-title":"Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells","volume":"92","author":"Chen","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbi.2010.02.002","article-title":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate","volume":"185","author":"Sertel","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1035","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00280-011-1643-7","article-title":"Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-kappaB pathway","volume":"68","author":"Wang","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1040","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4161\/15384047.2014.955728","article-title":"Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis","volume":"15","author":"Dong","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1045","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/ijmm.2015","article-title":"Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway","volume":"35","author":"Dong","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1050","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1582-4934.2010.01120.x","article-title":"Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties","volume":"15","author":"Soomro","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1055","first-page":"1929","article-title":"Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1","volume":"35","author":"Saeed","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.03.041","article-title":"Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin","volume":"588","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.niox.2008.04.008","article-title":"Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells","volume":"19","author":"Konkimalla","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/156800909787314020","article-title":"The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells","volume":"9","author":"Konkimalla","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1075","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00432-012-1292-1","article-title":"Growth inhibitory effect of dihydroartemisinin on Bcr\/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-kappaB modulation","volume":"138","author":"Lee","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1080","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1039\/c3mb70342h","article-title":"Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction","volume":"9","author":"Huang","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1085","first-page":"468","article-title":"Artemisinin inhibits neuroblastoma proliferation through activation of AHP-activated protein kinase (AMPK) signaling","volume":"69","author":"Tan","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1090","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/molecules15042886","article-title":"Pharmacogenomic identification of c-Myc\/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines","volume":"15","author":"Sertel","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fct.2013.02.017","article-title":"Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages","volume":"56","author":"Kim","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1100","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.bcp.2010.02.003","article-title":"Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha\/Raf\/MAPKs and NF-kappaB\/AP-1-dependent mechanisms","volume":"79","author":"Hwang","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1105","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.febslet.2008.02.055","article-title":"Human fortilin is a molecular target of dihydroartemisinin","volume":"582","author":"Fujita","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1115","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.7314\/APJCP.2014.15.6.2511","article-title":"Targeted efficacy of dihydroartemisinin for translationally controlled protein expression in a lung cancer model","volume":"15","author":"Liu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1120","doi-asserted-by":"crossref","first-page":"26314","DOI":"10.1074\/jbc.M114.568253","article-title":"Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors","volume":"289","author":"Kobayashi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.niox.2010.12.005","article-title":"Artesunate mitigates proliferation of tumor cells by alkylating heme-harboring nitric oxide synthase","volume":"24","author":"Zeng","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1130","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.1200919","article-title":"Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway","volume":"189","author":"Zhao","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1135","doi-asserted-by":"crossref","first-page":"87271","DOI":"10.18632\/oncotarget.13536","article-title":"Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappaB\/GLUT1 axis","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1140","doi-asserted-by":"crossref","first-page":"e0164838","DOI":"10.1371\/journal.pone.0164838","article-title":"Downregulation of HOTAIR expression mediated anti-Metastatic effect of artesunate on cervical cancer by inhibiting COX-2 expression","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1145","doi-asserted-by":"crossref","first-page":"16192","DOI":"10.1074\/jbc.273.26.16192","article-title":"The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin","volume":"273","author":"Bhisutthibhan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0171-9335(99)80052-1","article-title":"The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding","volume":"78","author":"Bhisutthibhan","year":"1999","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2012.10.006","article-title":"Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum","volume":"85","author":"Eichhorn","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00239-008-9099-z","article-title":"Phylogenetic and structural analysis of translationally controlled tumor proteins","volume":"66","author":"Hinojosa-Moya","year":"2008","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrc2589","article-title":"The molecular programme of tumour reversion: the steps beyond malignant transformation","volume":"9","author":"Telerman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tcb.2012.10.002","article-title":"Di fiore PP, telerman A. TPT1\/TCTP-regulated pathways in phenotypic reprogramming","volume":"23","author":"Amson","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1039\/c2mb05437j","article-title":"Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells","volume":"8","author":"Eichhorn","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1180","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1185","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0140-6736(90)93135-C","article-title":"Fenaux P, et al.v Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid","volume":"336","author":"Degos","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its dervatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1195","first-page":"1819","article-title":"Safety and efficacy field study of artesunate for dogs with non-resectable tumours","volume":"33","author":"Rutteman","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1200","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5326\/JAAHA-MS-6145","article-title":"Comparison of high-dose intermittent and low-dose continuous oral artemisinin in dogs with naturally occurring tumors","volume":"50","author":"Hosoya","year":"2014","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13659-014-0013-7","article-title":"Treatment of iron-Loaded veterinary sarcoma by artemisia annua","volume":"4","author":"Breuer","year":"2014","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1210","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.phymed.2011.06.008","article-title":"Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin","volume":"18","author":"Efferth","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1215","article-title":"Breakthroughs for Preventing and Surviving Cancer","year":"2002"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2298\/AOO0204279S","article-title":"Case report of a laryngeal squamous cell carcinoma treated with artesunate","volume":"10","author":"Singh","year":"2002","journal-title":"Arch. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1225","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma? First experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1230","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.phymed.2015.11.001","article-title":"Activity of Artemisia annua and artemisinin derivaitives in prostate carcinoma","volume":"22","author":"Michaelsen","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1235","article-title":"Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature","author":"Efferth T","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fonc.2016.00204","article-title":"Fatal liver and bone marrow toxicity by combination treatment of dichloroacetate and artesunate in a glioblastoma multiforme patient: case report and review of the literature","volume":"6","author":"Uhl","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1245","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3736\/jcim20080206","article-title":"Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial","volume":"6","author":"Zhang","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1250","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-Controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1260","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00498254.2013.878815","article-title":"Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies","volume":"44","author":"Ericsson","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1265","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.phymed.2013.04.003","article-title":"Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin","volume":"20","author":"Veerappan","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1270","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-016-2960-7","article-title":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study","volume":"77","author":"Konig","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1275","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acschembio.5b01043","article-title":"Profiling of multiple targets of artemisinin activated by hemin in cancer cell proteome","volume":"11","author":"Zhou","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1280","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.3390\/molecules161210556","article-title":"The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model","volume":"16","author":"Ma","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1285","doi-asserted-by":"crossref","first-page":"33046","DOI":"10.18632\/oncotarget.5422","article-title":"Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis","volume":"6","author":"Jeong da","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.02.009_bib1290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1423-0127-16-16","article-title":"Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells","volume":"16","author":"Lu","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2017.02.009_bib1295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/OTT.S81041","article-title":"Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2","volume":"8","author":"Zhang","year":"2015","journal-title":"Oncol. Targets Ther."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:07:57Z","timestamp":1719083277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X17300299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":259,"alternative-id":["S1044579X17300299"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.02.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}